VisionPoint Advisory Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$232K	Buy	+520	New	+$232K	0.05%	321
2024 Q3	–	Sell	-75	Closed	-$35.2K	–	774
2024 Q2	$35.2K	Buy	75 +24	+47%	+$11.2K	0.01%	328
2024 Q1	$21.3K	Buy	+51	New	+$21.3K	0.01%	374